These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7962779)

  • 21. Guidelines for routine liver biopsy during methotrexate treatment.
    Cash JM; Wilke WS
    Cleve Clin J Med; 1994; 61(4):317-8. PubMed ID: 7923752
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
    Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
    JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.
    Hassan W
    Ann Rheum Dis; 1996 May; 55(5):273-5. PubMed ID: 8660097
    [No Abstract]   [Full Text] [Related]  

  • 24. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.
    Kremer JM; Alarcón GS; Lightfoot RW; Willkens RF; Furst DE; Williams HJ; Dent PB; Weinblatt ME
    Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
    Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient increase of aminotransferases in RA patients treated with methotrexate.
    Lacki JK; Samborski W; Machiewicz SH
    Z Rheumatol; 1993; 52(4):232-5. PubMed ID: 8212923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate Hepatotoxicity Monitoring Guidelines in Psoriasis and Rheumatoid Arthritis: Is There a Consensus?
    Clary DD; Reid AT; Kiani R; Fanciullo J
    S D Med; 2021 Aug; 74(8):363-366. PubMed ID: 34461001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis.
    Fries JF; Singh G; Lenert L; Furst DE
    Arthritis Rheum; 1990 Nov; 33(11):1611-9. PubMed ID: 2242059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriasis-liver-methotrexate interactions.
    Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
    [No Abstract]   [Full Text] [Related]  

  • 30. Liver disease associated with methotrexate treatment of psoriatic patients.
    Dubin HV; Harrell ER
    Arch Dermatol; 1970 Nov; 102(5):498-503. PubMed ID: 5474111
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver disease in psoriatics--An effect of methotrexate therapy?
    Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
    Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
    [No Abstract]   [Full Text] [Related]  

  • 33. Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al.
    Fries JF; Ramey DR; Singh G
    Arthritis Rheum; 1994 Dec; 37(12):1829-30. PubMed ID: 7986233
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
    Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL
    Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver enzyme levels in arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M; von Dawson N
    Arthritis Rheum; 1992 Jan; 35(1):126-8. PubMed ID: 1346249
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
    Barker J; Horn EJ; Lebwohl M; Warren RB; Nast A; Rosenberg W; Smith C;
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):758-64. PubMed ID: 21198946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yazici Y; Erkan D; Paget SA
    J Rheumatol; 2002 Aug; 29(8):1586-9. PubMed ID: 12180713
    [No Abstract]   [Full Text] [Related]  

  • 39. A review of methotrexate-associated hepatotoxicity.
    Bath RK; Brar NK; Forouhar FA; Wu GY
    J Dig Dis; 2014 Oct; 15(10):517-24. PubMed ID: 25139707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.